BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angelico R, Blasi F, Manzia TM, Toti L, Tisone G, Cacciola R. The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature. Medicina (Kaunas) 2021;57:435. [PMID: 33946462 DOI: 10.3390/medicina57050435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Tseng HT, Wu XC, Huang CY, Shih CM, Lin YW, Lin FY. The Impact of SARS-CoV-2 Infection, and Application of Immunosuppressive Agents in Kidney Transplant Recipients Suffering from COVID-19. Pharmaceuticals (Basel) 2021;14:1054. [PMID: 34681278 DOI: 10.3390/ph14101054] [Reference Citation Analysis]
2 Sutharattanapong N, Thotsiri S, Kantachuvesiri S, Wiwattanathum P. Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients. Vaccines 2022;10:572. [DOI: 10.3390/vaccines10040572] [Reference Citation Analysis]
3 Liakopoulos V, Roumeliotis S, Papachristou S, Papanas N. COVID-19 and the kidney: time to take a closer look. Int Urol Nephrol 2021. [PMID: 34383205 DOI: 10.1007/s11255-021-02976-7] [Reference Citation Analysis]
4 Favi E, Cacciola R. Clinical and Surgical Challenges in Kidney Transplantation: Toward a Personalized Approach? Medicina 2022;58:604. [DOI: 10.3390/medicina58050604] [Reference Citation Analysis]
5 Devresse A, De Greef J, Yombi JC, Belkhir L, Goffin E, Kanaan N. Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients. Transplantation Direct 2022;8:e1292. [DOI: 10.1097/txd.0000000000001292] [Reference Citation Analysis]